Table 2 Correlations between LOS and AFR and other clinicopathological factors.
Univariate analysis | Multivariate analysis | |||
|---|---|---|---|---|
Hazard ratio (95%CI) | p-value | Hazard ratio (95%CI) | p-value | |
Sex | ||||
male | reference | |||
Female | 1.394 (0.891–2.181) | 0.146 | 1.863 (1.141–3.042) | 0.013 |
Age | ||||
≤ 60 | reference | |||
> 60 | 0.668 (0.474–0.942) | 0.022 | 0.695 (0.485–0.994) | 0.047 |
BMI | ||||
≤ 23.9 kg/m2 | reference | |||
> 23.9 kg/m2 | 0.826 (0.546–1.249) | 0.364 | ||
Tumor localization | ||||
Middle + Lower | reference | |||
Upper | 0.712 (0.399–1.271) | 0.251 | 0.639 (0.339–1.204) | 0.166 |
T | ||||
T1 | reference | |||
T2-4 | 1.053 (0.697–1.592) | 0.806 | ||
N | ||||
No Lymph Node Invasion | reference | |||
Lymph Node Invasion | 1.292 (0.918–1.818) | 0.141 | ||
AFR | ||||
≤ 10.34 | reference | |||
> 10.34 | 1.917 (1.351–2.719) | < 0.001 | 2.213 (1.405–3.017) | < 0.001 |
Erythrocyte count | ||||
≥ 3.5 *10^12/L | reference | |||
< 3.5 *10^12/L | 0.967 (0.521–1.798) | 0.917 | ||
Platelet counts | ||||
≤ 300*10^9/L | reference | |||
> 300*10^9/L | 1.431 (0.831–2.466) | 0.196 | 1.090 (0.574–2.070) | 0.792 |
Globulin | ||||
≤ 35 g/L | reference | |||
> 35 g/L | 0.565 (0.332–0.963) | 0.036 | 0.358 (0.188–0.679) | 0.002 |
Na + | ||||
≥ 135 mmol/L | reference | |||
< 135 mmol/L | 1.739(0.426–7.092) | 0.441 | ||
Cholesterol | ||||
≤ 6.10 mmol/L | reference | |||
> 6.10 mmol/L | 0.782 (0.529–1.157) | 0.218 | 1.642 (1.127–2.538) | 0.035 |
Neutrophil counts | ||||
≤ 7.0 × 10*9/L | reference | |||
> 7.0 × 10*9/L | 1.6088 (0.810–3.191) | 0.174 | 1.722 (0.844–3.512) | 0.135 |
Lymphocyte count | ||||
≥ 0.8 × 10^9/L | reference | |||
< 0.8*10^9/L | 1.440 (0.726–2.856) | 0.297 | 1.530 (0.741–3.159) | 0.250 |
Monocyte count | ||||
≤ 0.8 × 10^9/L | reference | |||
> 0.8 × 10^9/L | 0.569 (0.271–1.194) | 0.136 | 0.645 (0.286–1.453) | 0.290 |